THURSDAY, April 29 (HealthDayNews) -- An investigational drug called Ranexa may offer relief to people with angina, a chronic condition that causes chest pain and limits physical activity, according to a new study. It found the drug significantly increased the ability of angina patients to exercise. This study evaluated whether the drug was effective on its own and established the effective dosage amount. The study appeared in a recent issue of the Journal of the American College of Cardiology. A previous study found that when Ranexa was combined with current therapies to treat angina -- such as beta-blockers or calcium blockers -- it helped increase a patient's ability to exercise. Ranexa is currently under review by the U.S. Food and Drug Administration. More information The U.S. National Heart, Lung, and Blood Institute has more about angina. (SOURCE: Saint Louis University Health Sciences Center, news release, April 2004) Copyright © 2004 ScoutNews, LLC. All rights reserved. HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder® does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder® health library. |